Plurify are shaping the future of stem cell therapies. Their platform removes unwanted cells, one of the major bottlenecks and risks in cell therapy manufacture.

Plurify are a start-up born out of Deep Science Ventures and Cell and Gene Therapy Catapult, to solve the purification challenges in stem cell therapies

Find out more about Plurify here.